Burris, Howard A III
Okusaka, Takuji
Vogel, Arndt
Lee, Myung Ah
Takahashi, Hidenori
Breder, Valeriy
Blanc, Jean-Frédéric
Li, Junhe
Bachini, Melinda
Żotkiewicz, Magdalena
Abraham, Jayne
Patel, Nikunj
Wang, Julie
Ali, Muzammil
Rokutanda, Nana
Cohen, Gordon
Oh, Do-Youn
Funding for this research was provided by:
AstraZeneca Pharmaceuticals LP
This article is maintained by: Elsevier
Article Title: Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
Journal Title: The Lancet Oncology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S1470-2045(24)00082-2
Content Type: article
Copyright: © 2024 Elsevier Ltd. All rights reserved.